Foundational Pillars:

  • Target well-conserved and stable immunometabolic processes that could prove a successful strategy for therapeutic efficacy
  • Prioritize patient safety
  • Design targets to restore immune tolerance that may drive more durable clinical response and remission
  • Identify novel pathways with promising potential to innovate the treatment of autoimmune disease